Attached files
| file | filename |
|---|---|
| EX-31.1 - Pathfinder Cell Therapy, Inc. | v215984_ex31-1.htm |
| EX-2.1A - Pathfinder Cell Therapy, Inc. | v215984_ex2-1a.htm |
| EX-23.1 - Pathfinder Cell Therapy, Inc. | v215984_ex23-1.htm |
| EX-10.39 - Pathfinder Cell Therapy, Inc. | v215984_ex10-39.htm |
| EX-10.37 - Pathfinder Cell Therapy, Inc. | v215984_ex10-37.htm |
| EX-10.38 - Pathfinder Cell Therapy, Inc. | v215984_ex10-38.htm |
| EX-10.36A - Pathfinder Cell Therapy, Inc. | v215984_ex10-36a.htm |
| 10-K - Pathfinder Cell Therapy, Inc. | v215984_10k.htm |
EXHIBIT 32.1: CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
In connection with the accompanying Annual Report on Form 10-K of SyntheMed, Inc. for the fiscal year ended December 31, 2010, the undersigned hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of the undersigned’s knowledge and belief, that:
(1) such Annual Report on Form 10-K for the fiscal year ended December 31, 2010 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in such Annual Report on Form10-K for the fiscal year ended December 31, 2010 fairly presents, in all material respects, the financial condition and results of operations of SyntheMed, Inc.
|
March 25, 2011
|
/s/ Richard L. Franklin, M.D.
|
|
Name:
|
Richard L. Franklin, M.D.
|
||
|
Title: Executive Chairman and Chairman of the Board (principal
executive, financial and accounting officer)
|
|||